AVDL - Avadel Pharmaceuticals plc
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$21.43
DETAILS
HIGH:
$30.00
LOW:
$18.50
MEDIAN:
$20.00
CONSENSUS:
$21.43
DOWNSIDE:
0.97%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 91.0% |
| EBIT Margin | -22.6% |
| EBITDA Margin | -21.0% |
| Operating Margin | -25.1% |
| Pretax Margin | -29.0% |
| Cont. Ops Margin | -28.9% |
| Net Margin | -28.9% |
| Bottom Line Margin | -28.9% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 2.75 |
| Quick Ratio | 2.33 |
| Solvency Ratio | -0.511 |
| Cash Ratio | 1.05 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings | |
| PEG Ratio | 0.27 |
| Forward PEG | 0.27 |
| Price/Book | 13.54 |
| Price/Sales | 5.91 |
| Price/FCF | -21.32 |
| Price/Op Cash Flow | -21.32 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0104 |
| Debt/Equity | 0.0231 |
| Debt/Capital | 0.0226 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 2.22 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 1.85 |
| Operating Cash Flow Ratio | -0.961 |
| Operating Cash Flow/Sales | -27.7% |
| Free Cash Flow/Operating Cash Flow | 100.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -3.26 |
| Interest Coverage | -3.9150 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -27.53 |
| Capital Expenditure Coverage | 0.00 |
| Dividend + Capital Expenditure Coverage | 0.00 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 1.78 |
| EPS | -0.513 |
| Debt/Share | 0.1317 |
| Cash/Share | 0.78 |
| Book Value/Share | 0.78 |
| Tangible BV/Share | 0.60 |
| Equity/Share | 0.78 |
| Operating Cash Flow/Share | -0.493 |
| Capital Expenditure/Share | 0.000 |
| FCF/Share | -0.493 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.995 |
| Earnings Before Tax/EBIT | 1.158 |
| Price/Fair Value | 13.54 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | 0.5% |
| Enterprise Value Multiple | -26.72 |